Ambrohexal tabs 30mg #20

Instruction for Ambrohexal

Reed more and buy Ambrohexal on this page

The drug has a secretory, secretolytic and expectorant effect; stimulates the serous cells of the glands of the bronchial mucosa, increases the content of the mucous secretion and the release of surfactants in the alveoli and bronchi.
Normalizes the disturbed ratio of serous and mucous components of sputum. By activating hydrolyzing enzymes and enhancing the release of lysosomes from Clark cells, it reduces the viscosity of sputum.
AmbroHEXAL increases the motor activity of the ciliated epithelium, increases mucociliary clearance.
After oral administration in the form of tablets or syrup, Ambrohexal is rapidly and almost completely absorbed in the digestive tract. The relative bioavailability of the tablet form of the drug with respect to the soluble is approximately 100%.
Ambroxol is rapidly distributed in tissues. About 30% of the drug undergoes biotransformation in the liver. About 90% of ambroxol is excreted unchanged, some in the form of metabolites (mainly glucuronides).
The action of Ambrohexal begins after 30 minutes and lasts 6-12 hours.

Indications for use

What helps Ambrohexal? According to the instructions, the drug is prescribed in the following cases:
    Infectious bronchitis with acute or chronic course - inflammation of the bronchial mucosa caused by viruses or bacteria.
    Pneumonia is an inflammation of the lungs caused by various microorganisms.
    Bronchiectatic disease is a chronic pathological process with the expansion of part of the bronchi and bronchioles, in which viscous sputum accumulates.
    Bronchial asthma or atopic bronchitis is a pathology of an allergic nature, accompanied by a narrowing of the bronchi (bronchospasm) and the accumulation of thick sputum in their lumen.
    Tracheitis is an inflammatory process in the mucous membrane of the trachea caused by various causes, often an infection.
    Chronic obstructive bronchitis - the disease is often caused by prolonged irritation of the bronchial mucosa with various aggressive chemical compounds, in particular smoking.
    Cystic fibrosis is a severe hereditary disease in which viscous sputum is produced without an inflammatory reaction in the airways.
The effect of the drug is primarily on the pathogenesis of most inflammatory processes in the bronchial tree, namely the improvement of the protective function of the respiratory tract.

Instructions for use Ambrohexal, dosage

The tablets are taken orally after a meal, washed down with clean water.
Dosage of Ambrohexal tablets:
    Adults and children over 12 years old in the first three days - 1 tablet (30 mg) \ 3 times a day, with the transition to a maintenance dose - 1 tablet \ 2 times a day.
    Children aged 6 to 12 years are prescribed 1/2 tablet (15 mg) \ 2-3 times a day.
    Children under the age of 6 years - 1/2 tablet \ 1 time per day, preferably in the evening.

special instructions

During the course of treatment, it is necessary to use a significant amount of liquid, which will facilitate the process of liquefaction of sputum.
Do not combine Ambrohexal with antitussive drugs that inhibit cough, as this can lead to the accumulation of sputum in the bronchial tree and lungs.
With caution, the drug can be used with concomitant pathology of the liver or kidneys, while periodic monitoring of their functional activity is mandatory.
The use of medication before bedtime is not recommended.
Against the background of bronchial asthma, it can contribute to increased cough.

Side effects

The instruction warns of the possibility of developing the following side effects when prescribing AmbroHEXAL:
    stomach ache;
    nausea;
    constipation
    dry mouth
    increased salivation;
    increased secretion of mucus in the nasal cavity;
    dry airway;
    skin rashes;
    hives;
    angioedema;
    bronchospasm;
    fever and chills;
    anaphylactic shock;
    weakness;
    headache;
    difficulty urinating (dysuria).

Contraindications

It is contraindicated to appoint Ambrohexal in the following cases:
    1 trimester of pregnancy;
    children's age up to 6 years (for tablets);
    children's age up to 12 years (for prolonged action capsules);
    hypersensitivity to ambroxol and other components of the dosage form of the drug.
The use of the drug in the 2nd and 3rd trimesters of pregnancy is possible only if the intended benefit to the mother outweighs the potential risk to the fetus.
With caution, the drug should be used during breastfeeding, as ambroxol is excreted in breast milk.

Overdose

Overdose symptoms - increased salivation, dyspepsia, nausea, vomiting, gastralgia, diarrhea.
It is recommended to induce artificial vomiting, to do gastric lavage in the first 1-2 hours after taking the drug. The intake of fat-containing foods is recommended.

Terms of sell

You don't need a prescription to buy Ambrohexal.